+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-07-27Number of Pages: 87

Cardiopulmonary Stress Testing Systems Market (Cardiopulmonary Exercise Testing Systems, Stress ECG, Pulse Oximeters, Stress Blood Pressure Monitors, and SPECT) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Cardiopulmonary stress testing is performed to evaluate exercise capacity and predict outcome in patients diagnosed with heart failure. The cardiopulmonary stress testing systems market report studies the current and future prospects of the market globally. The report comprises an elaborate executive summary, which includes a market snapshot that provides overall information of various segments and sub-segments included in the study. This section also provides overall information and data analysis of the global cardiopulmonary stress testing systems market with respect to leading market segments based on type of product, and geography.

The market overview section of the report comprises qualitative analysis of the overall cardiopulmonary stress testing systems market, considering the factors determining the market dynamics such as drivers, restraints, and opportunities, along with Porter’s Five Forces Analysis and market attractiveness analysis. In addition, various analyses such as event impact analysis, regulatory framework, market attractiveness analysis by geography, and competitive landscape by key players have been provided. Event impact analysis includes the study of major events such as introduction of new technologies, mergers and acquisitions, and changes that significantly impacted the market. Regulatory framework includes the study of different regulatory norms and procedures that regulate the approval and commercialization of cardiopulmonary stress testing systems and techniques. The market attractiveness analysis is provided to explain the intensity of competition in the market in different geographies. The competitive scenario between different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players take strategic decisions in order to strengthen their positions and expand their shares in the global cardiopulmonary stress testing systems market.

The global cardiopulmonary stress testing systems market has been segmented on the basis of device type and geography. Based on device type, the cardiopulmonary stress testing systems market has been categorized into five key segments: cardiopulmonary exercise testing (CPET) systems, stress ECG, pulse oximeters, stress blood pressure monitors, and single-photon emission computed tomography (SPECT). Cardiopulmonary exercise testing (CPET) systems have been further categorized into two sub-segments: portable CPET systems and stationary CPET systems. Market revenue in terms of USD million for the period between 2013 and 2023 along with compound annual growth rate (CAGR %) from 2015 to 2023 are provided for all segments, considering 2014 as the base year.

Geographically, the cardiopulmonary stress testing systems market has been categorized into six regions: North America, Europe, Asia-Pacific, Latin America, the Middle East and North Africa, and Rest of the World (RoW). North America comprises the U.S. and Canada. Europe comprises Germany, the U.K., and Rest of Europe. Asia-Pacific comprises China, India, and Rest of Asia Pacific. Latin America comprises Brazil, Mexico, and Rest of Latin America. The Middle East and North Africa (MENA) comprises Saudi Arabia, the United Arab Emirates, and Rest of MENA. The recommendations section included in the report would assist existing players to expand their market share and new companies to establish their presence in the cardiopulmonary stress testing systems market. The report also profiles major players in the cardiopulmonary stress testing systems market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include CareFusion Corporation, COSMED, GE Healthcare, MGC Diagnostics Corporation, Nihon Kohden Corporation, Philips Healthcare, Schiller AG, Spacelabs Healthcare, SunTech Medical, Inc., and Welch Allyn, Inc. 

The global Cardiopulmonary Stress Testing Systems market is segmented as follows:

Global Cardiopulmonary Stress Testing Systems Market, by Product Type
  • Cardiopulmonary Exercise Testing (CPET) Systems
    • Portable CPET Systems
    • Desktop CPET Systems
  • Stress ECG
  • Pulse Oximeters
  • Stress Blood Pressure Monitors
  • SPECT
Global Cardiopulmonary Stress Testing Systems Market, by Geography
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
  • Rest of Europe
    • Asia-Pacific
    • China
    • India
    • Rest of Asia Pacific
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East and North Africa
    • Saudi Arabia
    • UAE
    • Rest of MENA
  • Rest of the World (RoW)


Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Secondary Research
1.3.2 Primary Research
1.4 Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Cardiopulmonary Stress Testing Systems Market (2014 & 2023)
2.2 Global Cardiopulmonary Stress Testing Systems Market Revenue, by Type, 2014 (USD Million)
2.3 Comparative Analysis: Global Cardiopulmonary Stress Testing Systems Market Revenue, by Geography, 2014 & 2023 (Value %)

Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Increasing prevalence of coronary artery disease
3.2.2 Rise in global obesity rate along with aging population likely to trigger demand for CPST systems
3.2.2.1 Absolute number of coronary heart disease deaths by decade of age, 2010 – 2040
3.2.3 Penetration of new monitoring technology greatly enhances diagnosis rate
3.3 Market Restraints
3.3.1 Implementation of legal provisions (e.g. Affordable Care Act) that promote cost containment/cost cutting strategies
3.3.2 Slow growth in the number of SPECT MPI procedures
3.4 Opportunities
3.4.1 Presence of a huge potential market in most emerging nations globally
3.5 Event Impact Analysis
3.6 Number of Cardiac Stress Test Procedures Performed from MPI SPECT Test in U.S. and Europe
3.7 Porter’s Five Forces Analysis of the Global Cardiopulmonary Stress Testing Systems Market
3.7.1 Bargaining power of suppliers
3.7.2 Bargaining power of buyers
3.7.3 Threat of substitutes
3.7.4 Threat of new entrants
3.7.5 Competitive rivalry
3.8 Market Attractiveness Analysis: Global Cardiopulmonary Stress Testing Systems Market, by Geography
3.9 Competitive Landscape
3.9.1 Market Share Analysis: Global Cardiopulmonary Stress Testing Systems Market, 2014 (Value %)
3.10 Regulatory Framework

Chapter 4 Global Cardiopulmonary Stress Testing Systems Market, by Product Type
4.1 Introduction
4.1.1 Global Cardiopulmonary Stress Testing Systems Market Revenue, by Types, 2013 – 2023 (USD Million)
4.2 Average Pricing Analysis
4.3 Cardiopulmonary Exercise Testing (CPET) Systems
4.3.1 Global CPET Systems Market Revenue, by Type, 2013 – 2023 (USD Million)
4.3.2 Portable CPET Systems
4.3.3 Global Portable CPET Systems Market Revenue, 2013 – 2023 (USD Million)
4.3.4 Stationary CPET Systems
4.3.5 Global Stationary CPET Systems Market Revenue, 2013 – 2023 (USD Million)
4.4 Stress ECG
4.4.1 Global Stress ECG Market Revenue, 2013 – 2023 (USD Million)
4.5 Pulse Oximeters
4.5.1 Global Pulse Oximeters Market Revenue, 2013 – 2023 (USD Million)
4.6 Stress Blood Pressure Monitors
4.6.1 Global Stress Blood Pressure Monitors Market Revenue, 2013 – 2023 (USD Million)
4.7 Single-Photon Emission Computed Tomography (SPECT)
4.7.1 Global SPECT Market Revenue, 2013 – 2023 (USD Million)

Chapter 5 Global Cardiopulmonary Stress Testing Systems Market, by Geography
5.1 Overview
5.1.1 Global Cardiopulmonary Stress Testing Systems Market Revenue, by Geography, 2013 – 2023 (USD Million)
5.2 North America : U.S. and Canada
5.2.1 North America Cardiopulmonary Stress Testing Systems Market Revenue, by Country, 2013 – 2023 (USD Million)
5.3 Europe : Germany, U.K. and Rest of Europe
5.3.1 Europe Cardiopulmonary Stress Testing Systems Market Revenue, by Country, 2013 – 2023 (USD Million)
5.4 Asia-Pacific (APAC) : India, China and Rest of APAC
5.4.1 Asia-Pacific Cardiopulmonary Stress Testing Systems Market Revenue, by Country, 2013 – 2023 (USD Million)
5.5 Latin America (LATAM) : Brazil, Mexico and Rest of LATAM
5.5.1 LATAM Cardiopulmonary Stress Testing Systems Market Revenue, by Country, 2013 – 2023 (USD Million)
5.6 MENA : Saudi Arabia, UAE and Rest of MENA
5.6.1 MENA Cardiopulmonary Stress Testing Systems Market Revenue, by Country, 2013 – 2023 (USD Million)
5.7 Rest of the World (RoW)
5.7.1 RoW Cardiopulmonary Stress Testing Systems Market Revenue, 2013 – 2023 (USD Million)

Chapter 6 Recommendations
6.1 Investing in emerging markets in Asia Pacific, Latin America, and Africa
6.2 Focus on improved and technologically advanced cardiopulmonary stress testing systems

Chapter 7 Company Profiles
7.1 CareFusion Corporation
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategies
7.1.5 Recent Developments
7.2 COSMED
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategies
7.2.5 Recent Developments
7.3 GE Healthcare
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Product Portfolio
7.3.4 Business Strategies
7.3.5 Recent Developments
7.4 MGC Diagnostics Corporation
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Product Portfolio
7.4.4 Business Strategies
7.4.5 Recent Developments
7.5 Nihon Kohden Corporation
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Product Portfolio
7.5.4 Business Strategies 
7.5.5 Recent Developments
7.6 Philips Healthcare
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Product Portfolio
7.6.4 Business Strategies
7.6.5 Recent Developments
7.7 Schiller AG
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Product Portfolio
7.7.4 Business Strategies
7.7.5 Recent Developments
7.8 Spacelabs Healthcare
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Product Portfolio
7.8.4 Business Strategies
7.8.5 Recent Developments
7.9 SunTech Medical, Inc.
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Product Portfolio
7.9.4 Business Strategies
7.9.5 Recent Developments
7.10 Welch Allyn, Inc.
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Product Portfolio
7.10.4 Business Strategies
7.10.5 Recent Developments

List of Figures

FIG. 1 Cardiopulmonary Stress Testing Systems: Market Segmentation
FIG. 2 Global Cardiopulmonary Stress Testing Systems Market, by Type, 2014 (USD Million)
FIG. 3 Comparative Analysis: Global Cardiopulmonary Stress Testing Systems Revenue, by Geography, 2014 & 2023 (Value %)
FIG. 4 Absolute number of coronary heart disease deaths by decade of age, 2010 – 2040
FIG. 5 Porter’s Five Forces Analysis: Global Cardiopulmonary Stress Testing Systems Market
FIG. 6 Market Attractiveness Analysis: Global Cardiopulmonary Stress Testing Systems Market, by Geography (2014)
FIG. 7 Market Share Analysis, by Key Players: Global Cardiopulmonary Stress Testing Systems Market, 2014 (Value %)
FIG. 8 Global Portable CPET Systems Market Revenue, 2013 – 2023 (USD Million)
FIG. 9 Global Stationary CPET Systems  Market Revenue, 2013 – 2023 (USD Million)
FIG. 10 Global Stress ECG Market Revenue, 2013 – 2023 (USD Million)
FIG. 11 Global Pulse Oximeters Market Revenue, 2013 – 2023 (USD Million)
FIG. 12 Global Stress Blood Pressure Monitors Market Revenue, 2013 – 2023 (USD Million)
FIG. 13 Global SPECT Market Revenue, 2013 – 2023 (USD Million)
FIG. 14 RoW Cardiopulmonary Stress Testing Systems Market Revenue, 2013 – 2023 (USD Million)
FIG. 15 CareFusion Corporation: Annual Revenue, 2012 – 2014 (USD Million)
FIG. 16 GE Healthcare: Annual Revenue, 2012 – 2014 (USD Million)
FIG. 17 MGC Diagnostic Corporation: Annual Revenue, 2012 – 2014 (USD Million)
FIG. 18 Nihon Kohden Corporation: Annual Revenue, 2012 – 2014 (USD Million)
FIG. 19 Philips Healthcare: Annual Revenue, 2012 – 2014 (USD Million)
FIG. 20 Spacelabs Healthcare: Annual revenue, 2012 – 2014 (USD Million)
FIG. 30 Medtronic, Plc., Annual Revenue: 2012 - 2014 (USD Million)
FIG. 31 Smiths Medical: Annual Revenue, 2012 – 2014 (USD Million)
FIG. 32 St. Jude Medical, Inc.: Annual Revenue, 2012 – 2014 (USD Million)
FIG. 33 Terumo Corporation: Annual Revenue, 2012 – 2014 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Cardiopulmonary Stress Testing Systems Market (2014 & 2023)
TABLE 2 Global Cardiopulmonary Stress Testing Systems Market Revenue, by Types, 2013 – 2023 (USD Million)
TABLE 3 Global CPET Systems Market Revenue, by Type, 2013 – 2023 (USD Million)
TABLE 4 Global Cardiopulmonary Stress Testing Systems Market Revenue, by Geography, 2013 – 2023 (USD Million)
TABLE 5 North America Cardiopulmonary Stress Testing Systems Market Revenue, by Country, 2013 – 2023 (USD Million)
TABLE 6 Europe Cardiopulmonary Stress Testing Systems Market Revenue, by Country, 2013 – 2023 (USD Million)
TABLE 7 Asia-Pacific Cardiopulmonary Stress Testing Systems Market Revenue, by Country, 2013 – 2023 (USD Million)
TABLE 8 LATAM Cardiopulmonary Stress Testing Systems Market Revenue, by Country, 2013 – 2023 (USD Million)
TABLE 9 MENA Cardiopulmonary Stress Testing Systems Market Revenue, by Country, 2013 – 2023 (USD Million)

The cardiopulmonary stress testing systems market comprises devices that assist in the evaluation of exercise capacity of an individual and predict outcome in patients diagnosed with heart failure. The primary goal of cardiac stress testing is to identify the risk stratification of coronary artery disease (CAD), which is one of the most common causes of deaths globally. Diagnosis and monitoring of cardiopulmonary disorders is rapidly gaining importance in the health care industry in order to prevent the rapid rise in deaths due to increasing prevalence of various cardiovascular and pulmonary disorders. Factors such as aging population, rising incidence of cardiopulmonary disorders, and increasing awareness about the risks associated with cardiopulmonary disorders would contribute to the growth of the cardiopulmonary stress testing systems market. Furthermore, global increase in the number of hospitals is likely to generate fresh demand for cardiopulmonary stress testing systems.

The global cardiopulmonary stress testing systems market has been segmented on the basis of product type and geography. Based on product type, the cardiopulmonary stress testing systems market has been categorized into five key segments: cardiopulmonary exercise testing (CPET) systems, stress ECG, pulse oximeters, stress blood pressure monitors, and single-photon emission computed tomography (SPECT). Cardiopulmonary exercise testing (CPET) systems have been categorized into two sub-segments: portable CPET systems and stationary CPET systems. CPET was the largest segment of the global cardiopulmonary stress testing systems market. Rise in prevalence of cardiac diseases, rapid growth in geriatric population, and technical advancements are the major factors boosting the global cardiopulmonary stress testing systems market. Furthermore, rise in incidence of coronary artery disease, increase in lifestyle disorders, and growth in disposable income are likely to propel the market during the forecast period.

Geographically, North America held the largest share of the global cardiopulmonary stress testing systems market in terms of revenue in 2014, followed by Europe. These two regions are expected to retain their leadership positions throughout the forecast period from 2015 to 2023. The dominance of these two regions was majorly due to large pool of cardiopulmonary patients and presence of a large number of hospitals that are increasingly adopting innovative products. China and India are the major markets in Asia-Pacific that offer large opportunities for cardiopulmonary stress testing systems manufacturers. The cardiopulmonary stress testing systems market in Asia-Pacific is projected to expand at the highest CAGR during the forecast period. Brazil and Mexico are the major countries in Latin America where the cardiopulmonary stress testing systems market is expected to record strong growth.

Philips Healthcare, GE Healthcare, CareFusion Corporation, Spacelabs Healthcare, COSMED, MGC Diagnostic Corporation, Nihon Kohden Corporation, Schiller AG, SunTech Medical, Inc. and Welch Allyn are the major players operating in the global cardiopulmonary stress testing systems market. Philips Healthcare, GE Healthcare, CareFusion Corporation, and Spacelabs Healthcare operate in most of the segments of the cardiopulmonary stress testing systems market at a global level.

cardiopulmonary-stress-testing-systems


A complete brochure for this research is available for download.

Interact with our pool of experienced analysts for any report related queries